Form 4: Precigen Director Steven Frank Acquires Shares and Stock Units
SEC Form 4 Filing
Director Steven Frank acquired shares and restricted stock units in Precigen, Inc. on March 14, 2024.
Summary
- On March 14, 2024, Steven Frank, a director of Precigen, Inc., acquired 34,965 shares of common stock at a price of $1.43 per share in lieu of an annual retainer of $50,000.
- Frank also acquired 87,412 restricted stock units (RSUs), each representing a contingent right to receive one share of Precigen common stock, which vest in full on March 14, 2025.
- Additionally, Frank acquired an option to purchase 101,626 shares of common stock at an exercise price of $1.43, expiring on March 14, 2034.
- Following these transactions, Frank beneficially owns 1,024,160 shares of Precigen common stock, 87,412 RSUs, and an option to purchase 101,626 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The director's acquisition of shares and RSUs could be interpreted as a positive sign, but it's not definitively bullish.
Positives
- The acquisition of shares and stock units by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting of RSUs on March 14, 2025, implies a future event.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.
Comparison to Industry Standards
- Insider transactions are a common occurrence in publicly traded companies, and the reporting requirements are standardized by the SEC.
- The acquisition of shares in lieu of a retainer is not uncommon, as it aligns the director's interests with those of the shareholders.
- The vesting schedule of the RSUs is typical, often spanning one to several years to incentivize long-term commitment.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's investment in the company.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of transaction: acquisition of common stock, RSUs, and stock options. |
| 03/14/2025 | Vesting date for the 87,412 Restricted Stock Units (RSUs). |
| 03/14/2034 | Expiration date for the option to purchase 101,626 shares of common stock. |
| 03/18/2024 | Date of signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.